Schedule 13G ownership disclosure

Madrigal Pharmaceuticals Inc

Common Stock, $0.0001 par value per share · CUSIP: 558868105

Event date: 2025-12-31

Filing-level shares
1,707,522
Percent of class
7.5%
  • PAULSON & CO. INC.

    Shares: 1,707,522 · Class: 7.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-26-000264
Form type
SCHEDULE 13G/A
Filer
MADRIGAL PHARMACEUTICALS, INC.
CIK
CIK 1157601
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub